|
Merck Receives 'Approvable' Letter from FDA on New Drug Application for ARCOXIA (MRK) 31.22: The FDA has informed Merck in the letter that before approval of the NDA can be issued, additional safety and efficacy data for ARCOXIA are required. "We continue to believe that ARCOXIA has the potential to become a valuable treatment option for many Americans with arthritis and pain... We plan to work with the FDA to address what steps need to be taken before the application may be approved."
MRK 8:11AM ET 32.00 +0.43 (+1.36%)
__________________
liebe Grüße von Coco
|